Metabolism, protein and miRNA cross-talk in cell cycle and tumor progression

细胞周期和肿瘤进展中的代谢、蛋白质和 miRNA 串扰

• 批准号: 8624665
• 负责人: DAVID M. HOCKENBERY
• 金额: $ 35.42万
• 依托单位: FRED HUTCHINSON CANCER RESEARCH CENTER
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-05-01 至 2017-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8624665
• 关键词: Address; Affect; Anabolism; Antineoplastic Agents; Arachidonic Acids; Bioenergetics; Cell Cycle; Cell division; Cells; Cholesterol; Cyclooxygenase Inhibitors; Dinoprostone; Disease; Down-Regulation; Environment; Enzymes; Equilibrium; Fatty Acids; Fibroblasts; Gene Proteins; Histone Acetylation; Investigation; Lead; Link; Lipids; MYC gene; Membrane; Membrane Microdomains; Metabolic; Metabolic Pathway; Metabolism; MicroRNAs; Mitotic Cell Cycle; Modeling; Neoplasm Metastasis; Nutrient; Nutritional; Oncogenes; Palmitates; Pathway interactions; Post-Translational Protein Processing; Process; Proliferating; Prostaglandins; Proteins; Proteomics; Regulation; Relative (related person); Reliance; Research; Research Personnel; Role; Saturated Fatty Acids; Signal Transduction; Signal Transduction Pathway; Source; Sphingolipids; Systems Biology; Toxic effect; Work; aerobic glycolysis; autocrine; cancer cell; cell growth; desaturase; indexing; inhibitor/antagonist; insight; lipid biosynthesis; lipid metabolism; neoplastic; neoplastic cell; novel; novel strategies; nutrient metabolism; oncogene addiction; oxidation; palmitoylation; paracrine; programs; protein metabolism; protein transport; ras Proteins; scaffold; stable isotope; stem cell division; tumor; tumor initiation; tumor progression; tumorigenic; uptake

DESCRIPTION (provided by applicant): In neoplastic diseases, cellular reprogramming for continued proliferation, invasion and metastasis are essential for tumor initation and progression. An increased understanding of oncogene regulation of these processes is essential to successful therapy. Our research has focused on the essential role of altered bioenergetics and biosynthetic metabolism during cell cycle entry and tumor progression regulated by the oncogene c-Myc. We have recently developed a novel approach to trace metabolism of nutrients and their direct contribution to protein modifications and demonstrated regulation of histone acetylation by substrate supply during Myc-dependent cell cycle entry, a previously unappreciated connection between metabolism and post-translational modifications. Increased lipid biosynthesis in Myc-expressing cells may increase protein targeting to lipid rafts and our preliminary studies indicate increased raft-associated Ras protein during Myc- induced cell cycle entry. We also demonstrated increased prostaglandin E2 in media, and that cyclooxygenase inhibitors had selective anti-proliferative effects for Myc-expressing cells. Lastly, our stable isotope studies with a Myc inducible/regressible tumor model show that tumor initiation, progression and regression are associated with distinct alterations in metabolic flux, setting up a potential for endogenous lipotoxicity from saturated fatty acids after Myc inactivation. These results lead us to hypothesize that Myc directs metabolism in synergistic pathways to promote cell cycling and cell growth, and that loss of this integration is a cause of Myc oncogene addiction. We propose the following specific aims to address these hypotheses. Specific Aim 1. To analyze changes in lipid raft composition during Myc-dependent cell cycle entry. Specific Aim 2. To analyze the requirements for arachidonic acid metabolism during Myc-dependent cell cycle entry. Specific Aim 3. To determine the role of lipotoxicity in Myc oncogene addiction. Together these studies have the potential to change current paradigms regarding control of signaling networks, to provide insight into proteins and miRNAs that participate in alteration of cell fates during programming of cells from quiescent to proliferative and tumorigenic states, and to reveal mechanisms underlying oncogene addiction.

描述（由申请人提供）：在肿瘤疾病中，细胞重编程持续增殖、侵袭和转移对肿瘤的发生和发展至关重要。增加对这些过程的癌基因调控的了解是成功治疗的关键。我们的研究集中在改变生物能量学和生物合成代谢在细胞周期进入和肿瘤进展中由癌基因c-Myc调节的重要作用。我们最近开发了一种新的方法来追踪营养物质的代谢及其对蛋白质修饰的直接贡献，并证明了myc依赖性细胞周期进入期间底物供应对组蛋白乙酰化的调节，这是代谢和翻译后修饰之间以前未被认识到的联系。在表达Myc的细胞中，脂质生物合成的增加可能会增加靶向脂筏的蛋白，我们的初步研究表明，在Myc诱导的细胞周期进入过程中，筏相关Ras蛋白增加。我们还证明了培养基中前列腺素E2的增加，并且环氧化酶抑制剂对表达myc的细胞具有选择性的抗增殖作用。最后，我们对Myc诱导/可逆肿瘤模型的稳定同位素研究表明，肿瘤的发生、发展和消退与代谢通量的明显改变有关，这可能导致Myc失活后饱和脂肪酸产生内源性脂肪毒性。这些结果使我们假设Myc通过协同途径指导代谢以促进细胞循环和细胞生长，而这种整合的丧失是Myc癌基因成瘾的原因之一。我们提出以下具体目标来解决这些假设。具体目标分析myc依赖性细胞周期进入时脂质筏组成的变化。具体目标2。分析myc依赖性细胞周期进入对花生四烯酸代谢的需求。具体目标3。确定脂肪毒性在Myc癌基因成瘾中的作用。总之，这些研究有可能改变目前关于信号网络控制的范式，为细胞从静止状态到增殖和致瘤状态的编程过程中参与细胞命运改变的蛋白质和mirna提供见解，并揭示癌基因成瘾的潜在机制。